title: A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy.
abstract: To investigate the role of extracorporeal detoxification in cirrhotic patients with advanced hepatic encephalopathy not responding to medical treatment, 20 patients were randomized to receive six hours of additional sorbent dialysis or ongoing standardized medical treatment. Following treatment, the clinical stage of encephalopathy remained unchanged in both groups. Abnormal sensory evoked potentials improved following sorbent dialysis (N70 latency, 128 ms before versus 110 ms after treatment, P<0,05; cervico-cranial transmission, 7.7 ms versus 6.8 ms, P<0.01) indicating improvement in important aspects of cerebral function. In contrast, brain function remained unchanged following medical treatment (N70 latency, 114 ms versus 113 ms; cervico-cranial transmission, 7.7 ms versus 7.2 ms, P=NS, respectively). Serum benzodiazepine levels decreased significantly after sorbent dialysis but not after medical treatment. Biocompatibility of sorbent dialysis was limited and clinical complications occurred in a proportion of patients. In conclusion, a six-hour treatment with sorbent suspension dialysis did not ameliorate the clinical stage of HE but improved neurophysiologic function in cirrhotic patients who had not responded to conventional medical treatment.
authors.affiliation: Department of Medicine IV, University of Vienna Medical School, Austria. ludwig.kramer@akh-wien.ac.at
authors.forename: L
authors.initials: L
authors.lastname: Kramer
authors.forename: A
authors.initials: A
authors.lastname: Gendo
authors.forename: C
authors.initials: C
authors.lastname: Madl
authors.forename: K D
authors.initials: KD
authors.lastname: Mullen
authors.forename: K
authors.initials: K
authors.lastname: Kaminski-Russ
authors.forename: G
authors.initials: G
authors.lastname: Sunder-Plassmann
authors.forename: A
authors.initials: A
authors.lastname: Schaffer
authors.forename: E
authors.initials: E
authors.lastname: Bauer
authors.forename: E
authors.initials: E
authors.lastname: Roth
authors.forename: P
authors.initials: P
authors.lastname: Ferenci
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D002908:Chronic Disease; D015314:Dialysis Solutions / Q000627:therapeutic use*; D004569:Electroencephalography; D005073:Evoked Potentials, Somatosensory; D005260:Female; D006501:Hepatic Encephalopathy / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D015314:Dialysis Solutions